Salix, Progenics announce date for Relistor advisory committee

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor

Salix Pharmaceuticals (SLXP +5.2%) and Progenics Pharmaceuticals (PGNX) finally get a date for an Advisory Committee meeting regarding the companies' appeal of the complete response letter the FDA issued for Relistor in OIC for patients with chronic pain.

The committee will convene on March 10-11 next year, after which time action on the appeal is expected within 30 days. (PR)

Back in June, SLXP and PGNX noted that they were "optimistic that with the [help of the] FDA and guidance from the Advisory Committee, a path forward" could be found for the drug.